Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Elevance Health, Inc. (NYSE: ELV)
ELV Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
14%
Analyst Rating:
BUY
Analyst Forecast (1yr):
5.50%
ELV Stock Analysis
ELV
PE Ratio:
16.6
ELV
PEG Ratio:
2
ELV
Forward EPS Growth (12 month):
8.30%
ELV
PS Ratio:
0.4
ELV
PSG Ratio:
0.2
ELV
Forward Revenue Growth (12 month):
2.50%
ELV Articles
No data was found